2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Mouth Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HR; Chen, JY; Cheng, YP; Chiang, MK; Ji, WT; Lee, YR; Wu, WC | 1 |
1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Mouth Neoplasms
| Article | Year |
|---|---|
Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Down-Regulation; Flow Cytometry; Fluorescent Antibody Technique; Humans; Male; Morpholines; Mouth Neoplasms; Proto-Oncogene Proteins c-akt; Purines; TOR Serine-Threonine Kinases | 2012 |